Immune clues in the blood may predict IVF success

NCT ID NCT05473273

Recruiting now Knowledge-focused Sponsor: ART Fertility Clinics LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks immune-related substances in the blood of 40 women undergoing a frozen embryo transfer. Researchers want to see how these markers change before and after the transfer, and whether they relate to pregnancy success. The goal is to better understand the role of the immune system in implantation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Estradiol valerate and progesterone (Endometrin)
What this could lead to: If successful, this study could help doctors understand which immune markers are linked to successful embryo implantation, potentially improving fertility treatments.
What could go wrong: This is a small, early observational study (40 participants) that only measures markers—it does not test a new treatment. Results may not lead to direct changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female infertility infertility disorder long QT syndrome 3

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY, FEMALE

Contacts and locations

Locations

ART Fertility Clinics LLC
RECRUITING

Abu Dhabi, Abu Dhabi Emirate, 60202, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.